253 related articles for article (PubMed ID: 30783052)
1. Current Status of p16 Immunohistochemistry and HPV Testing in Fine Needle Aspiration Specimens of the Head and Neck.
Jalaly JB; Hosseini SM; Shafique K; Baloch ZW
Acta Cytol; 2020; 64(1-2):30-39. PubMed ID: 30783052
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of p16 immunohistochemistry and increased sensitivity of RNA in situ hybridization in cytology specimens of HPV-related head and neck squamous cell carcinoma.
Wong KS; Krane JF; Jo VY
Cancer Cytopathol; 2019 Oct; 127(10):632-642. PubMed ID: 31509355
[TBL] [Abstract][Full Text] [Related]
3. p16 immunostaining in cytology specimens: its application, expression, interpretation, and challenges.
Ribeiro EA; Maleki Z
J Am Soc Cytopathol; 2021; 10(4):414-422. PubMed ID: 33422456
[TBL] [Abstract][Full Text] [Related]
4. Correlation of p16 immunostaining in cell-blocks with corresponding tissue specimens for squamous cell carcinomas of the oropharynx.
Song SJ; Jalaly JB
Cytopathology; 2021 Jan; 32(1):100-107. PubMed ID: 32886831
[TBL] [Abstract][Full Text] [Related]
5. The utility of p16 immunostaining in fine needle aspiration in p16-positive head and neck squamous cell carcinoma.
Xu B; Ghossein R; Lane J; Lin O; Katabi N
Hum Pathol; 2016 Aug; 54():193-200. PubMed ID: 27105759
[TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of p16 expression in FNA specimens from head and neck squamous cell carcinoma and correlation with HPV status.
Abi-Raad R; Prasad ML; Gilani S; Garritano J; Barlow D; Cai G; Adeniran AJ
Cancer Cytopathol; 2021 May; 129(5):394-404. PubMed ID: 33369885
[TBL] [Abstract][Full Text] [Related]
7. The Fidelity of p16 Staining as a Surrogate Marker of Human Papillomavirus Status in Fine-Needle Aspirates and Core Biopsies of Neck Node Metastases: Implications for HPV Testing Protocols.
Holmes BJ; Maleki Z; Westra WH
Acta Cytol; 2015; 59(1):97-103. PubMed ID: 25765380
[TBL] [Abstract][Full Text] [Related]
8. Hybrid Capture 2 human papillomavirus testing of fine needle aspiration cytology of head and neck squamous cell carcinomas.
Hakima L; Adler E; Prystowsky M; Schiff B; Schlecht N; Fox A; Suhrland M; Khader SN
Diagn Cytopathol; 2015 Sep; 43(9):683-7. PubMed ID: 25964135
[TBL] [Abstract][Full Text] [Related]
9. HPV-related squamous cell carcinoma of the head and neck: An update on testing in routine pathology practice.
Bishop JA; Lewis JS; Rocco JW; Faquin WC
Semin Diagn Pathol; 2015 Sep; 32(5):344-51. PubMed ID: 25724476
[TBL] [Abstract][Full Text] [Related]
10. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.
Patel KR; Chernock RD; Zhang TR; Wang X; El-Mofty SK; Lewis JS
Hum Pathol; 2013 Nov; 44(11):2385-92. PubMed ID: 24071016
[TBL] [Abstract][Full Text] [Related]
11. β-Catenin Expression in Oropharyngeal Squamous Cell Carcinomas: Comparison and Correlation with p16 and Human Papillomavirus in situ Hybridization.
Nwanze J; Cohen C; Schmitt AC; Siddiqui MT
Acta Cytol; 2015; 59(6):479-84. PubMed ID: 26849661
[TBL] [Abstract][Full Text] [Related]
12. ROC analysis of p16 expression in cell blocks of metastatic head and neck squamous cell carcinoma.
Wilson BL; Israel AK; Ettel MG; Lott Limbach AA
J Am Soc Cytopathol; 2021; 10(4):423-428. PubMed ID: 33906829
[TBL] [Abstract][Full Text] [Related]
13. Fine-needle aspiration of cervical lymph nodes yields adequate materials for accurate HPV testing in metastatic head and neck squamous cell carcinomas.
Hou Y; Chaudhary S; Shen R; Li Z
Diagn Cytopathol; 2016 Oct; 44(10):792-8. PubMed ID: 27465660
[TBL] [Abstract][Full Text] [Related]
14. p16 expression in cutaneous squamous cell carcinoma of the head and neck is not associated with integration of high risk HPV DNA or prognosis.
Satgunaseelan L; Chia N; Suh H; Virk S; Ashford B; Lum T; Ranson M; Clark J; Gupta R
Pathology; 2017 Aug; 49(5):494-498. PubMed ID: 28663082
[TBL] [Abstract][Full Text] [Related]
15. p16 immunostaining in fine-needle aspirations of the head and neck: determining the optimal positivity threshold in HPV-related squamous cell cancer.
Wang Q; Zhou F; Snow JT; Simsir A; Hernandez O; Levine P; Szeto O; Sun W; Givi B; Brandler TC
J Am Soc Cytopathol; 2021; 10(6):592-600. PubMed ID: 34326027
[TBL] [Abstract][Full Text] [Related]
16. Automated RNA In Situ Hybridization for 18 High Risk Human Papilloma Viruses in Squamous Cell Carcinoma of the Head and Neck: Comparison With p16 Immunohistochemistry.
Drumheller B; Cohen C; Lawson D; Siddiqui MT
Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):160-164. PubMed ID: 28777152
[TBL] [Abstract][Full Text] [Related]
17. The role of human papillomavirus in p16-positive oral cancers.
Belobrov S; Cornall AM; Young RJ; Koo K; Angel C; Wiesenfeld D; Rischin D; Garland SM; McCullough M
J Oral Pathol Med; 2018 Jan; 47(1):18-24. PubMed ID: 29024035
[TBL] [Abstract][Full Text] [Related]
18. A novel prediction model for human papillomavirus-associated oropharyngeal squamous cell carcinoma using p16 and subcellular β-catenin expression.
Qian G; Hu Z; Xu H; Müller S; Wang D; Zhang H; Kim S; Chen Z; Saba NF; Shin DM; Wang AY; Chen ZG
J Oral Pathol Med; 2016 Jul; 45(6):399-408. PubMed ID: 26493274
[TBL] [Abstract][Full Text] [Related]
19. A simplified molecular method to detect high-risk HPV using the Aptima HPV assay on head and neck FNA smears.
Gormley JP; Selvaggi SM; Rehrauer WM; Kucher ET
Cancer Cytopathol; 2023 Mar; 131(3):171-178. PubMed ID: 36287090
[TBL] [Abstract][Full Text] [Related]
20. Is p16 immunohistochemistry a more cost-effective method for identification of human papilloma virus-associated head and neck squamous cell carcinoma?
Thomas J; Primeaux T
Ann Diagn Pathol; 2012 Apr; 16(2):91-9. PubMed ID: 22197546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
